Following treatment with MMSN@Dox, both CRT expression and extracellular HMGB1 levels were significantly increased, indicating that the chemoamplifier MMSN@Dox can effectively enhance ICD, which provides a favorable prerequisite for activating anti-tumor immune responses. This evidence concerns the gene HMGB1 and neoplasm.